- Home
- KRKR vs HOTH Comparison
KRKR vs HOTH Comparison
Compare KRKR & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- HOTH
- Stock Information
- Founded
- KRKR 2010
- HOTH 2017
- Country
- KRKR China
- HOTH United States
- Employees
- KRKR N/A
- HOTH N/A
- Industry
- KRKR Business Services
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- HOTH Health Care
- Exchange
- KRKR Nasdaq
- HOTH Nasdaq
- Market Cap
- KRKR 7.6M
- HOTH 7.6M
- IPO Year
- KRKR 2019
- HOTH 2019
- Fundamental
- Price
- KRKR $3.10
- HOTH $0.84
- Analyst Decision
- KRKR
- HOTH Strong Buy
- Analyst Count
- KRKR 0
- HOTH 4
- Target Price
- KRKR N/A
- HOTH $4.75
- AVG Volume (30 Days)
- KRKR 6.5K
- HOTH 2.1M
- Earning Date
- KRKR 12-05-2024
- HOTH 11-12-2024
- Dividend Yield
- KRKR N/A
- HOTH N/A
- EPS Growth
- KRKR N/A
- HOTH N/A
- EPS
- KRKR N/A
- HOTH N/A
- Revenue
- KRKR $41,654,350.00
- HOTH N/A
- Revenue This Year
- KRKR $45.99
- HOTH N/A
- Revenue Next Year
- KRKR $31.46
- HOTH N/A
- P/E Ratio
- KRKR N/A
- HOTH N/A
- Revenue Growth
- KRKR N/A
- HOTH N/A
- 52 Week Low
- KRKR $3.03
- HOTH $0.58
- 52 Week High
- KRKR $14.88
- HOTH $1.73
- Technical
- Relative Strength Index (RSI)
- KRKR 30.80
- HOTH 47.24
- Support Level
- KRKR $3.03
- HOTH $0.77
- Resistance Level
- KRKR $3.71
- HOTH $1.02
- Average True Range (ATR)
- KRKR 0.27
- HOTH 0.07
- MACD
- KRKR -0.07
- HOTH -0.01
- Stochastic Oscillator
- KRKR 5.37
- HOTH 30.77
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.